Under construction – not a live service
Sign in

2022-502633-26-00RecruitingPhase 3

Does peri-operative treatment with Tranexamic Acid reduce the early relapse rate for patients with melanoma; a randomised controlled trial

Perioperative treatment with Tranexamic Acid (TXA) in melanoma; prognostic and treatment related impact of the plasminogen-plasmin pathway

Source: EU CTIS (euclinicaltrials.eu) · Last updated 28 Jul 2026

Next steps

Brief summary (registry, in English)

To test if perioperative treatment with TXA is superior to placebo and reduces the early relapse rates by >10%, for patients diagnosed with melanoma undergoing sentinel lymph node biopsy surgery.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
638 (estimated)
First submitted
30 Nov 2022
Start date
25 Aug 2023
Lead sponsor
Aarhus University Hospital
Diseases
Melanoma
EU CT number
2022-502633-26-00

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 638
  • 7 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Lab values

  • Patients: With prior history of invasive melanoma Thromboembolic events within the last 3 months Pregnancy * Active breast feeding Known allergy or hypersensitivity to TXA Known and treated epilepsia or previous seizures eGFR 0-50

Who the study is looking for

  • Patients: Diagnosed with invasive cutaneous melanoma (pathological stage/tumor grade higher than T2b), defined as either: Breslow thickness >1.0-2.0 mm with presence of ulceration or Breslow thickness >2.0 mm regardless of ulceration status Eligible for surgery (wide local excision and sentinel lymph node biopsy). >/=18 years of age and </=80 years of age Signed Informed Consent Form

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (7)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Aalborg University HospitalAalborgDenmarkRecruiting
Aarhus University HospitalAarhus NDenmarkRecruiting
RigshospitaletCopenhagen OeDenmarkRecruiting
Herlev HospitalHerlevDenmarkRecruiting
Odense University HospitalOdense CDenmarkRecruiting
Zealand University HospitalRoskildeDenmarkRecruiting
Lillebaelt HospitalVejleDenmarkRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.